Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Affibody and Creative Antibiotics to collaborate on targeted antibiotics

Feb. 3, 2012

Eusa Pharma acquires Asparec rights

Feb. 2, 2012

Impax Pharmaceuticals gains U.S. rights to migraine therapy

Feb. 2, 2012

Shire and Sangamo BioSciences enter agreement for hemophilia therapeutics

Feb. 2, 2012

Astellas and UCB sign Japanese development and commercialization agreement for Cimzia

Feb. 1, 2012

Spectrum Pharmaceuticals in-licenses long-acting granulocyte colony-stimulating factor

Feb. 1, 2012

Takeda returns Posidur rights to Durect

Jan. 31, 2012

Orexo ends collaboration with Janssen

Jan. 31, 2012

Servier and Monash University establish GPCR collaboration

Jan. 31, 2012

Navidea Biopharmaceuticals enters into agreement for Parkinson's disease imaging agent

Jan. 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...